Cover Image
Market Research Report
Product code 
949727

Neurological Biomarker Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product ; Application ; End User ; and Geography

Published: | The Insight Partners | 168 Pages | Delivery time: 1-2 business days

Price

Back to Top
Neurological Biomarker Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product ; Application ; End User ; and Geography
Published: June 24, 2020
The Insight Partners
Content info: 168 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

Title:
Neurological Biomarker Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Others); Application (Alzheimer's Disease, Parkinson's Disease, Schizophrenia, Huntington's Disease, Spinal Muscular Atrophy, Others); End User (Pharmaceutical and Biotechnology Companies, Clinical Diagnostics, Research Organizations); and Geography.

The global neurological biomarker market is expected to reach US$ 5,501.8 million by 2027 from US$ 14,454.7 million in 2019; it is estimated to grow at a CAGR of 13.0% from 2020 to 2027.The rising prevalence of neurological diseases and growing focus on neurological biomarker researchare the major factorsdriving the growth of the neurological biomarker market. However, the concerns associated with biomarker such as measurement errors and cost hindersthe growth of the market.

Neurological diseases contribute to a significant burden on health systems in terms of disease diagnosis, treatment, and management. Epilepsy, Alzheimer's disease, multiple sclerosis, spinal muscular atrophy (SMA), and Duchenne muscular dystrophy are among the major neurological disorders. According to the Global Burden of Disease Study, in 2016, neurological disorders are the main cause of disability-adjusted life-years (DALYs) and the second major cause of deaths. Stroke (42.2%), migraine (16.3%), Alzheimer's, and other dementias (10.4%) are among the four most significant neurological diseases causing DALYs.As per the 2019 Alzheimer's disease Facts and Figures Report, in 2019, ~5.8 million Americans of all ages were suffering from Alzheimer's dementia. Among 5.8 million patients, 81% of the patients were aged 75 years and above. Thus, the increasing prevalence of neurological diseases is a major factor driving the growth of the global neurological biomarker market during the forecast period.

The global neurological biomarker market is segmented on the basis of product, application, and end user. Based on product, the market is segmented into proteomics biomarker, genomics biomarker, metabolomics biomarker, imaging biomarker, and others. In 2019, genomics biomarker held the largest share of the market; moreover, the market for the same is expected to grow at the fastest CAGR during the forecast period.Based on application, the neurological biomarker marketis segmented into Alzheimer's disease, Parkinson's disease, schizophrenia, Huntington's disease, spinal muscular atrophy, and others.On the basis of enduser, the neurological biomarker markethas been segmented into pharmaceutical and biotechnology companies, clinical diagnostics, and research organizations.

The Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), European Federation of Pharmaceuticals Industries Associations, European Medical Association, Biomarkers Biospecimen and Data Repository, Global Burden of Disease,and Boston University School of Medicineare a few of the essential secondary sources referred to while preparing this report.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the neurological biomarker market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global neurological biomarker market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPRE00003515

Table of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Neurological Biomarker Market - By Product
    • 1.3.2 Neurological Biomarker Market - By Application
    • 1.3.3 Neurological Biomarker Market - By End User
    • 1.3.4 Global Neurological Biomarker Market - By Geography

2. Neurological Biomarker Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Neurological Biomarker Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific- PEST Analysis
    • 4.2.4 Middle East and Africa - PEST Analysis
    • 4.2.5 South & Central America
  • 4.3 Expert Opinion

5. Neurological Biomarker Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rising Prevalence of Neurological Diseases
    • 5.1.2 Growing Focus on Neurological Biomarker Research
  • 5.2 Key Market Restraints
    • 5.2.1 Concerns Associated with Biomarkers
  • 5.3 Key Market Opportunities
    • 5.3.1 Increasing Awareness of Neurological Diseases Coupled with Developing Healthcare Infrastructure
  • 5.4 Future Trends
    • 5.4.1 The Rising Trend of Precision/Personalized Healthcare
  • 5.5 Impact analysis

6. Neurological Biomarker Market - Global Analysis

  • 6.1 Global Neurological Biomarker Market Revenue Forecast And Analysis
  • 6.2 Global Neurological Biomarker Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Neurological Biomarker Market Analysis- by Product

  • 7.1 Overview
  • 7.2 Neurological Biomarker Market Share, By Product, 2019 & 2027 (%)
    • 7.2.1 Neurological Biomarker Market Revenue and Forecasts to 2027, By Product(US$ Mn)
  • 7.3 Proteomics Biomarker
    • 7.3.1 Overview
    • 7.3.2 Proteomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.4 Genomics Biomarker
    • 7.4.1 Overview
    • 7.4.2 Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.5 Metabolomics Biomarker
    • 7.5.1 Overview
    • 7.5.2 Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.6 Imaging Biomarker
    • 7.6.1 Overview
    • 7.6.2 Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. Neurological Biomarker Market Analysis- by Application

  • 8.1 Overview
  • 8.2 Neurological Biomarker Market Share, By Application, 2019 & 2027 (%)
    • 8.2.1 Neurological Biomarker Market Revenue and Forecasts to 2027, By Application (US$ Mn)
  • 8.3 Alzheimer's Disease
    • 8.3.1 Overview
    • 8.3.2 Alzheimer's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.4 Parkinson's Disease
    • 8.4.1 Overview
    • 8.4.2 Parkinson's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.5 Schizophrenia
    • 8.5.1 Overview
    • 8.5.2 Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.6 Huntington's Disease
    • 8.6.1 Overview
    • 8.6.2 Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.7 Spinal Muscular Atrophy
    • 8.7.1 Overview
    • 8.7.2 Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)

9. Neurological Biomarker Market Analysis- by End User

  • 9.1 Overview
  • 9.2 Neurological Biomarker Market Share, By End User, 2019 & 2027 (%)
    • 9.2.1 Neurological Biomarker Market Revenue and Forecasts to 2027, By End User (US$ Mn)
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.4 Clinical Diagnostics
    • 9.4.1 Overview
    • 9.4.2 Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.5 Research Organizations
    • 9.5.1 Overview
    • 9.5.2 Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)

10. Neurological Biomarker Market Analysis And Forecasts To 2027 - Geographical Analysis

  • 10.1 North America: Neurological Biomarker Market
    • 10.1.1 Overview
    • 10.1.2 North America: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 North America: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
    • 10.1.4 North America: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
    • 10.1.5 North America: Neurological Biomarker Market, by End-User , 2018-2027 (USD Million)
    • 10.1.6 North America: Neurological Biomarker Market, by Country, 2019& 2027 (%)
    • 10.1.7 US: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 US: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 US: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.1.7.3 US: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
      • 10.1.7.4 US: Neurological Biomarker Market, by End-User , 2018-2027 (USD Million)
    • 10.1.8 Canada: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Canada: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Canada: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.1.8.3 Canada: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
      • 10.1.8.4 Canada: Neurological Biomarker Market, by End-User , 2018-2027 (USD Million)
    • 10.1.9 Mexico: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 Mexico: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 Mexico: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.1.9.3 Mexico: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
      • 10.1.9.4 Mexico: Neurological Biomarker Market, by End-User , 2018-2027 (USD Million)
  • 10.2 Europe: Neurological Biomarker Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
    • 10.2.3 Europe: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
    • 10.2.4 Europe: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
    • 10.2.5 Europe: Neurological Biomarker Market, by End-User , 2018-2027 (USD Million)
    • 10.2.6 Europe: Neurological Biomarker Market, by Country, 2019& 2027 (%)
    • 10.2.7 Germany: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.1 Germany: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.2 Germany: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.2.7.3 Germany: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
      • 10.2.7.4 Germany: Neurological Biomarker Market, by End-User , 2018-2027 (USD Million)
    • 10.2.8 United Kingdom: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.1 United Kingdom: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.2 United Kingdom: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.2.8.3 United Kingdom: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
      • 10.2.8.4 United Kingdom: Neurological Biomarker Market, by End-User, 2018-2027 (USD Million)
    • 10.2.9 France: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.1 France: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.2 France: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.2.9.3 France: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
      • 10.2.9.4 France: Neurological Biomarker Market, by End-User , 2018-2027 (USD Million)
    • 10.2.10 Spain: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.1 Spain: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.2 Spain: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.2.10.3 Spain: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
      • 10.2.10.4 Spain: Neurological Biomarker Market, by End-User , 2018-2027 (USD Million)
    • 10.2.11 Italy: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.1 Italy: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.2 Italy: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.2.11.3 Italy: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
      • 10.2.11.4 Italy: Neurological Biomarker Market, by End-User , 2018-2027 (USD Million)
  • 10.3 Asia Pacific: Neurological Biomarker Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
    • 10.3.3 Asia Pacific: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
    • 10.3.4 Asia Pacific: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
    • 10.3.5 Asia Pacific: Neurological Biomarker Market, by End-User , 2018-2027 (USD Million)
    • 10.3.6 Asia Pacific: Neurological Biomarker Market, by Country, 2019& 2027 (%)
    • 10.3.7 China: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.1 China: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.2 China: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.3.7.3 China: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
      • 10.3.7.4 China: Neurological Biomarker Market, by End-User , 2018-2027 (USD Million)
    • 10.3.8 Japan: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.1 Japan: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.2 Japan: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.3.8.3 Japan: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
      • 10.3.8.4 Japan: Neurological Biomarker Market, by End-User , 2018-2027 (USD Million)
    • 10.3.9 India: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.1 India: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.2 India: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.3.9.3 India: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
      • 10.3.9.4 India: Neurological Biomarker Market, by End User, 2018-2027 (USD Million)
    • 10.3.10 South Korea: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.1 South Korea: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.2 South Korea: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.3.10.3 South Korea: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
      • 10.3.10.4 South Korea: Neurological Biomarker Market, by End User, 2018-2027 (USD Million)
    • 10.3.11 Australia: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.1 Australia: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.2 Australia: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.3.11.3 Australia: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
      • 10.3.11.4 Australia: Neurological Biomarker Market, by End User, 2018-2027 (USD Million)
  • 10.4 Middle East and Africa: Neurological Biomarker Market
    • 10.4.1 Overview
    • 10.4.2 Middle East and Africa: Neurological Biomarker Market- Revenue and Forecast to 2027 (USD Million)
    • 10.4.3 Middle East and Africa: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
    • 10.4.4 Middle East and Africa: Neurological Biomarker Market, by Application, 2018-2027 (Million Units)
    • 10.4.5 Middle East and Africa: Neurological Biomarker, Market, by End User, 2018-2027 (USD Million)
    • 10.4.6 Middle East and Africa: Neurological Biomarker Market, by Country, 2019 & 2027 (%)
    • 10.4.7 Saudi Arabia: Neurological Biomarker Market- Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.1 Saudi Arabia: Neurological Biomarker Market- Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.2 Saudi Arabia: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.4.7.3 Saudi Arabia: Neurological Biomarker Market, by Application, 2018-2027 (Million Units)
      • 10.4.7.4 Saudi Arabia: Neurological Biomarker, Market, by End User, 2018-2027 (USD Million)
    • 10.4.8 UAE: Neurological Biomarker Market- Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.1 UAE: Neurological Biomarker Market- Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.2 UAE: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.4.8.3 UAE: Neurological Biomarker Market, by Application, 2018-2027 (Million Units)
      • 10.4.8.4 UAE: Neurological Biomarker, Market, by End User, 2018-2027 (USD Million)
    • 10.4.9 South Africa: Neurological Biomarker Market- Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.1 South Africa: Neurological Biomarker Market- Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.2 South Africa: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.4.9.3 South Africa: Neurological Biomarker Market, by Application, 2018-2027 (Million Units)
      • 10.4.9.4 South Africa: Neurological Biomarker, Market, by End User, 2018-2027 (USD Million)
  • 10.5 South and Central America: Neurological Biomarker Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Neurological Biomarker Market - Revenue and Forecast to 2027 (US$ Million)
    • 10.5.3 South and Central America: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
    • 10.5.4 South and Central America: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
    • 10.5.5 South and Central America: Neurological Biomarker Market, by End User, 2018-2027 (USD Million)
    • 10.5.6 South and Central America: Neurological Biomarker Market, by Country, 2019 & 2027 (%)
    • 10.5.7 Brazil: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.1 Brazil: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.2 Brazil: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.5.7.3 Brazil: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
      • 10.5.7.4 Brazil: Neurological Biomarker Market, by End User, 2018-2027 (USD Million)
    • 10.5.8 Argentina: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.1 Argentina: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.2 Argentina: Neurological Biomarker Market, by Product, 2018-2027 (USD Million)
      • 10.5.8.3 Argentina: Neurological Biomarker Market, by Application, 2018-2027 (USD Million)
      • 10.5.8.4 Argentina: Neurological Biomarker Market, by End User, 2018-2027 (USD Million)

11. Impact of COVID-19 Pandemic on Global Neurological Biomarker Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment Of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
  • 12.4.1 Overview

13. Company Profiles

  • 13.1 Thermo Fisher Scientific Inc.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Abbott
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Myriad Genetics, Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Bio-Rad Laboratories Inc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 QIAGEN
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Banyan Biomarkers, Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Immunarray Pvt. Ltd.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Quest Diagnostics Incorporated
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Perkin Elmer, Inc.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 MERCK KGaA
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 Glossary of Terms

List Of Tables

  • Table 1. Neurological Biomarker Market Revenue And Forecasts to 2027, By Product(US$ Mn)
  • Table 2. Neurological Biomarker Market Revenue and Forecasts to 2027, By Application (US$ Mn)
  • Table 3. Neurological Biomarker Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 4. North America Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 5. North America Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 6. North America Neurological Biomarker Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 7. US Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 8. US Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 9. US Neurological Biomarker Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 10. Canada Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Canada Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Canada Neurological Biomarker Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 13. Mexico Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Mexico Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Mexico Neurological Biomarker Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 16. Europe Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Europe Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Europe Neurological Biomarker Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 19. Germany Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 20. Germany Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Germany Neurological Biomarker Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 22. United Kingdom Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 23. United Kingdom Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 24. United Kingdom Neurological Biomarker Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 25. France Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 26. France Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 27. France Neurological Biomarker Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 28. Spain Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 29. Spain Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 30. Spain Neurological Biomarker Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 31. Italy Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 32. Italy Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Italy Neurological Biomarker Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 34. Asia Pacific Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 35. Asia Pacific Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 36. Asia Pacific Neurological Biomarker Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 37. China Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 38. China Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 39. China Neurological Biomarker Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 40. Japan Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 41. Japan Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 42. Japan Neurological Biomarker Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 43. India Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 44. India Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 45. India Neurological Biomarker Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 46. South Korea Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 47. South Korea Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 48. South Korea Neurological Biomarker Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 49. Australia Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 50. Australia Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 51. Australia Neurological Biomarker Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 52. Middle East and Africa Neurological Biomarker Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 53. Middle East and Africa Neurological Biomarker Market, by Application- Volume and Forecast to 2027 (Million Units)
  • Table 54. Middle East and Africa Neurological Biomarker Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 55. Saudi Arabia Neurological Biomarker Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 56. Saudi Arabia Neurological Biomarker Market, by Application- Volume and Forecast to 2027 (Million Units)
  • Table 57. Saudi Arabia Neurological Biomarker Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 58. UAE Neurological Biomarker Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 59. UAE Neurological Biomarker Market, by Application- Volume and Forecast to 2027 (Million Units)
  • Table 60. UAE Neurological Biomarker Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 61. South Africa Neurological Biomarker Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 62. South Africa Neurological Biomarker Market, by Application- Volume and Forecast to 2027 (Million Units)
  • Table 63. South Africa Neurological Biomarker Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 64. South and Central America Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 65. South and Central America Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 66. South and Central America Neurological Biomarker Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 67. Brazil Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 68. Brazil Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 69. Brazil Neurological Biomarker Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 70. Argentina Neurological Biomarker Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 71. Argentina Neurological Biomarker Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 72. Argentina Neurological Biomarker Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 73. Organic Developments Done By Companies
  • Table 74. Inorganic Developments Done By Companies
  • Table 75. Glossary of Terms, Neurological Biomarker Market

List Of Figures

  • Figure 1. Neurological Biomarker Market Segmentation
  • Figure 2. Neurological Biomarker Market - By Geography
  • Figure 3. Global Neurological Biomarker Market Overview
  • Figure 4. Genomic Biomarkers Segment Held Largest Share of Neurological Biomarker Market
  • Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
  • Figure 6. Global Neurological Biomarker Market, By Geography (US$ Million)
  • Figure 7. Global Neurological Biomarker Market, Industry Landscape
  • Figure 8. Global Neurological Biomarker Market- Leading Country Markets (US$ Million)
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East and Africa PEST Analysis
  • Figure 13. South & Central America PEST Analysis
  • Figure 14. Expert Opinion
  • Figure 15. Neurological Biomarker Market Impact Analysis of Driver and Restraint
  • Figure 16. Global Neurological Biomarker Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 17. Global Neurological Biomarker Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 18. Market Positioning of Key Players
  • Figure 19. Neurological Biomarker Market Share, by Product, 2019 & 2027 (%)
  • Figure 20. Proteomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 21. Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 22. Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 23. Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 24. Others Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 25. Neurological Biomarker Market Share, by Application, 2019 & 2027 (%)
  • Figure 26. Alzheimer's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 27. Parkinson's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 28. Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 29. Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 30. Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 31. Others Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 32. Neurological Biomarker Market Share, by End User, 2019 & 2027 (%)
  • Figure 33. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 34. Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 35. Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 36. North America: Neurological Biomarker Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 37. North America Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)
  • Figure 38. North America: Neurological Biomarker Market, by Country, 2019 & 2027 (%)
  • Figure 39. US: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 40. Canada: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 41. Mexico: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 42. Europe: Neurological Biomarker Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 43. Europe Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)
  • Figure 44. Europe: Neurological Biomarker Market, by Country, 2019& 2027 (%)
  • Figure 45. Germany: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 46. United Kingdom: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 47. France: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 48. Spain: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 49. Italy: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 50. Asia Pacific: Neurological Biomarker Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 51. Asia Pacific Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)
  • Figure 52. China: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. Japan: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. India: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 55. South Korea: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 56. Australia: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 57. Middle East and Africa: Neurological Biomarker Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 58. Middle East and Africa Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)
  • Figure 59. Middle East and Africa: Neurological Biomarker Market, by Country, 2019 & 2027 (%)
  • Figure 60. Saudi Arabia: Neurological Biomarker Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 61. UAE: Neurological Biomarker Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 62. South Africa: Neurological Biomarker Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 63. South and Central America: Neurological Biomarker Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 64. South and Central America Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)
  • Figure 65. South and Central America: Neurological Biomarker Market, by Country, 2019 & 2027 (%)
  • Figure 66. Brazil: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 67. Argentina: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 68. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 69. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 70. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 71. Impact of COVID-19 Pandemic in Rest of the World Countries Market
  • Figure 72. Growth Strategies Done by the Companies in the Market, (%)